Standout Papers
- Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis (2022)
- Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials (2021)
Immediate Impact
1 from Science/Nature 70 standout
Citing Papers
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Works of Brian Calimlim being referenced
Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
2016
The Impact of Uncontrolled Asthma on Absenteeism and Health-Related Quality of Life
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Brian Calimlim | 730 | 446 | 288 | 66 | 1.3k | |
| Peter Anderson | 264 | 199 | 287 | 49 | 1.3k | |
| Mandeep Kaur | 862 | 293 | 201 | 98 | 1.6k | |
| I. Zschocke | 633 | 153 | 123 | 57 | 1.3k | |
| Usha G. Mallya | 307 | 212 | 167 | 49 | 996 | |
| Ronit Confino‐Cohen | 420 | 677 | 243 | 71 | 1.6k | |
| Amy Mulick | 315 | 216 | 157 | 56 | 1.5k | |
| Kevin R. Patel | 1325 | 791 | 442 | 50 | 1.6k | |
| S.E. Marrón | 1040 | 224 | 128 | 55 | 1.4k | |
| Brad Shumel | 838 | 709 | 448 | 58 | 1.2k | |
| Rukmini Rajagopalan | 492 | 283 | 92 | 47 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...